Legal & General Group Plc Buys New Stake in HealthEquity, Inc. $HQY

Legal & General Group Plc purchased a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 118,522 shares of the company’s stock, valued at approximately $10,705,000.

Several other hedge funds and other institutional investors have also made changes to their positions in HQY. The Manufacturers Life Insurance Company purchased a new position in shares of HealthEquity during the second quarter valued at about $7,306,000. Van Hulzen Asset Management LLC purchased a new position in HealthEquity during the 2nd quarter valued at approximately $452,000. Ranger Investment Management L.P. purchased a new position in HealthEquity during the 2nd quarter valued at approximately $28,835,000. Sanctuary Advisors LLC bought a new stake in HealthEquity in the 2nd quarter worth approximately $605,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new stake in HealthEquity in the 2nd quarter worth approximately $1,836,000. Institutional investors own 99.55% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on HQY shares. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research report on Friday. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, August 22nd. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Telsey Advisory Group set a $111.00 price objective on shares of HealthEquity in a research report on Friday. Finally, BTIG Research reissued a “buy” rating and issued a $115.00 price objective on shares of HealthEquity in a research note on Friday. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $111.87.

Insiders Place Their Bets

In other HealthEquity news, EVP Michael Henry Fiore sold 2,470 shares of the stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the sale, the executive vice president owned 56,643 shares in the company, valued at $5,381,085. This trade represents a 4.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Adrian T. Dillon sold 7,632 shares of HealthEquity stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 12,456 shares of company stock valued at $1,256,664. 1.60% of the stock is owned by company insiders.

HealthEquity Stock Up 0.2%

Shares of NASDAQ HQY opened at $96.54 on Tuesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The company has a market cap of $7.98 billion, a P/E ratio of 34.85, a PEG ratio of 1.53 and a beta of 0.21. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62. The firm has a 50-day simple moving average of $98.40 and a two-hundred day simple moving average of $88.06.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The firm had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. The business’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.